Brief: Shilpa Medicare Says Europe GMP Approval Of Shilpa Medicare Unit 4, Jadcherla, Telangana
16/04/2024 12:33
April 16 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* EUROPE GMP APPROVAL OF SHILPA MEDICARE UNIT 4, JADCHERLA,
TELANGANA
* UNIT 4, JADCHERLA; TELANGANA, INDIA INSPECTED BY AGES,
AUSTRIA
FROM 22 JAN UNTIL 26 JAN
* FOLLOWING SUCCESSFUL INSPECTION, UNIT ISSUED GMP
CERTIFICATION
FROM AGES, AUSTRIA
Source text for Eikon: ID:nBSE7R6kRJ
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026